angiotensin ii, des-phe(8)- has been researched along with 8,11,14-eicosatrienoic acid in 4 studies
| Studies (angiotensin ii, des-phe(8)-) | Trials (angiotensin ii, des-phe(8)-) | Recent Studies (post-2010) (angiotensin ii, des-phe(8)-) | Studies (8,11,14-eicosatrienoic acid) | Trials (8,11,14-eicosatrienoic acid) | Recent Studies (post-2010) (8,11,14-eicosatrienoic acid) |
|---|---|---|---|---|---|
| 1,533 | 21 | 995 | 1,478 | 35 | 424 |
| Protein | Taxonomy | angiotensin ii, des-phe(8)- (IC50) | 8,11,14-eicosatrienoic acid (IC50) |
|---|---|---|---|
| Oxoeicosanoid receptor 1 | Homo sapiens (human) | 2 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andreatta-van Leyen, S; Douglas, JG; Khosla, MC; Romero, MF | 1 |
| Cosic, A; Drenjancevic, I; Falck, JR; Kibel, A; Mihaljevic, Z; Novak, S | 1 |
| Bürgelová, M; Červenka, L; Hammock, BD; Husková, Z; Hwang, SH; Imig, JD; Melenovský, V; Sadowski, J; Škaroupková, P; Sporková, A | 1 |
| Červenka, L; Doleželová, Š; Falck, JR; Husková, Z; Imig, JD; Jíchová, Š; Kompanowska-Jezierska, E; Kopkan, L; Kramer, HJ; Kujal, P; Neckář, J; Reddy, RN; Sadowski, J; Vernerová, Z | 1 |
4 other study(ies) available for angiotensin ii, des-phe(8)- and 8,11,14-eicosatrienoic acid
| Article | Year |
|---|---|
Modulation of phospholipase A2 activity and sodium transport by angiotensin-(1-7).
Topics: 8,11,14-Eicosatrienoic Acid; Angiotensin I; Angiotensin II; Animals; Biological Transport; Cells, Cultured; Kidney Tubules, Proximal; Lysophosphatidylcholines; Male; Peptide Fragments; Phospholipases A; Phospholipases A2; Rabbits; Sodium | 1993 |
Hyperbaric oxygenation modulates vascular reactivity to angiotensin-(1-7) in diabetic rats: potential role of epoxyeicosatrienoic acids.
Topics: 8,11,14-Eicosatrienoic Acid; Amides; Angiotensin I; Angiotensin II; Animals; Aorta, Thoracic; Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 Enzyme System; Cytochrome P450 Family 2; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Enzyme Induction; Enzyme Inhibitors; Hyperbaric Oxygenation; Male; Oxidative Stress; Peptide Fragments; Rats, Sprague-Dawley; Steroid 16-alpha-Hydroxylase; Vascular Resistance; Vasoconstriction; Vasodilation; Vasodilator Agents | 2015 |
Inhibition of soluble epoxide hydrolase does not improve the course of congestive heart failure and the development of renal dysfunction in rats with volume overload induced by aorto-caval fistula.
Topics: 8,11,14-Eicosatrienoic Acid; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzoates; Disease Models, Animal; Drug Evaluation, Preclinical; Epoxide Hydrolases; Epoxy Compounds; Heart Failure; Kidney; Male; Myocardium; Peptide Fragments; Random Allocation; Rats; Renal Insufficiency; Renin-Angiotensin System; Ultrasonography; Urea | 2015 |
Epoxyeicosatrienoic acid analog attenuates the development of malignant hypertension, but does not reverse it once established: a study in Cyp1a1-Ren-2 transgenic rats.
Topics: 8,11,14-Eicosatrienoic Acid; Albuminuria; Angiotensin I; Angiotensin II; Animals; Blood Pressure; Cytochrome P-450 CYP1A1; Hypertension, Malignant; Indoles; Kidney; Male; Peptide Fragments; Rats; Rats, Transgenic; Renin; Renin-Angiotensin System; Time Factors | 2016 |